Dr. Allan Jordan, Head of Chemistry at the Drug Discovery Unit, Cancer Research UK Manchester Institute, describes how the institute is translating research into new cancer treatments. Jordan explains how he explores new, potential compounds capable of interfering with cancer cells as a start-point for targeted and personalized cancer therapies. Jordan utilizes acoustic liquid dispensing to dose reduced volumes of compounds to be investigated, enabling a higher quality and quantity of data to be produced, and so accelerating his research.